MedPath

Effect of the Intensity of Continuous Renal Replacement Therapy

Not Applicable
Completed
Conditions
Optimal Intensity of Renal Replacement Therapy on Sepsis Patients
Interventions
Other: extra high volume hemofiltration
Other: high volume hemofiltration
Registration Number
NCT01251081
Lead Sponsor
Zhejiang University
Brief Summary

In patients with sepsis and AKI, increasing the intensity of renal replacement therapy from 50 mL/kg/h (HVHF) to 85 mL/kg/h (EHVHF)will increase the survival at 28 days and 90 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria

met at least one of the following criteria: oliguria (urine output less than 100 mL in a 6 h period and unresponsive to fluid resuscitation), serum potassium concentration more than 6.5 mmol/L, severe acidemia (pH < 7.2), serum creatinine more than 250 µmol/L, or presence of severe organ edema (e.g. pulmonary edema).

Exclusion Criteria
  • were presence of a malignant tumor, chronic renal insufficiency (serum creatinine >133 µmol/L), or receiving any kind of renal replacement therapy before randomization.

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
extra high volume hemofiltrationextra high volume hemofiltrationextra high volume hemofiltration (85 mL/kg/h, EHVHF)
high volume hemofiltrationhigh volume hemofiltrationhigh volume hemofiltration (50 mL/kg/h, HVHF)
Primary Outcome Measures
NameTimeMethod
90 days survival

The primary study outcome was death from any cause within 90 days. Results were analyzed by Kaplan-Meier survival curves

Secondary Outcome Measures
NameTimeMethod
length of stay in the ICU and hospital

Secondary outcomes were length of stay in the ICU and hospital and renal outcome of survivors at 90 days after randomization.

Trial Locations

Locations (1)

Kidney disease center, the first affiliated hospital, medical college of Zhejiang university

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath